AMIA Report

Medical Informatics News

Medical Informatics RSS Feed

RSS Feeds

Advertise

 

            Home | News | White Papers | Buyer's Guide  

Industry Highlights

 Informatics White Papers

Informatics Market Reports

Informatics Buyer's Guide

Informatics Training

Informatics Resources

 

Informatics News

Informatics Press Releases

Informatics RSS Feeds

Informatics Company List

Informatics Events

Informatics Stocks

Informatics Books

 Informatics Jobs
 
 

AMIA Report

 
AMIA Releases Report Outlining Recommendations for a National Framework on the Secondary Use of Health Data

Other Toipcs: EDIS Emergency Department Information Systems, Medical Communication Systems

U.S. Newswire
September 11, 2006

Bethesda, MD -- The American Medical Informatics Association (AMIA) has released a report today entitled "Toward a National Framework for the Secondary Use of Health Data". This report is the result of an expert panel meeting convened earlier this year by AMIA.

As health data have proliferated, the realization of the potential value of the information has grown. The use of health data can not only enhance health care experiences for individuals, but also expand knowledge about disease and appropriate treatments, strengthen understanding about the effectiveness and efficiency of our health care systems, support public health and security goals, and aid businesses in meeting the needs of their customers. Yet, access to and use of aggregated data poses complex ethical, political, technical, and social challenges. Many of the issues surrounding the secondary use of health data are not new. These issues are however increasingly critical and complex in light of public and private sector activities that are expanding the volume of data available to be used and the availability of tools to access that health data.
 

 
The lack of coherent policies and practices for the secondary use of health data presents a significant impediment to the goal of strengthening the U.S. health system. A national framework for the secondary use of health data that includes a robust infrastructure of policies, standards, and best practices is needed to facilitate the broad and repeated collection, storage, aggregation, linkage, and transmission of health data with appropriate protections for legitimate secondary use.

The report includes five (5) key recommendations:
  • Recommendation 1: Increase the transparency of data use and public awareness;
  • Recommendation 2: Focus ongoing discussions on data access, use, and control (not on ownership);
  • Recommendation 3a: Continue discussions on privacy policy and security with regard to the secondary use of health data;
  • Recommendation 3b: Increase public awareness efforts on the benefits and challenges associated with the secondary use of health data;
  • Recommendation 4a: Create a taxonomy of the secondary use of health data;
  • Recommendation 4b: Address increasingly difficult current and evolving questions related to the secondary use of health data in a comprehensive manner; and
  • Recommendation 5: Focus national and state attention on the secondary use of health data.

"The need for national leadership in this area will be critical for gaining and keeping the public's trust as electronic health records become more prevalent," said Charles Safran, MD, MS, Past-Chairman, AMIA; Associate Clinical Professor of Medicine, Harvard Medical School/Beth Israel Deaconess Medical Center who spearheaded this effort. "Patients do not know who has access to their data and for what purposes. The expert panel learned of financial incentives for sharing of patient data that raises ethical questions and underscores the urgent need for further discussions and development of appropriate public policy in this area." stated Paul Tang, MD, AMIA Chairman.

Over thirty experts and key stakeholders from government, industry, and academia participated in the meeting to produce the report and its key findings and recommendations. A number of organizations helped support the project including GlaxoSmithKline, Lockheed Martin, Pfizer, GE Healthcare, IBM, Intelligent Medical Objects (IMO), Medstat, and RemedyMD.

Remarks by David Brailer (as the National Coordinator for Health Information Technology) and presentations from Doug Barton (Lockheed Martin), Blake Caldwell (Centers for Disease Control and Prevention (CDC), Nancy Davenport-Ennis (National Patient Advocate Foundation), Stan N. Finkelstein (Harvard -MIT), Melissa Goldstein (Markle Foundation, Connecting for Health), Michael I. Lieberman (GE Healthcare), Eleanor Perfetto (Pfizer) and Kevin Tabb (Stanford Hospital and Clinics) helped to shape the discussions and findings.

For a copy of the report, visit the AMIA Web site at: http://www.amia.org/inside/initiatives/healthdata.asp

The American Medical Informatics Association (AMIA) is an organization of leaders shaping the future of health information technology in the United States and abroad. AMIA is dedicated to the development and application of medical informatics in support of patient care, teaching, research, and health care administration. Complete information about AMIA is available at: http://www.amia.org.

http://www.usnewswire.com/

 
 

Home

White Papers Equipment Company List Market Reports RSS Feeds Training Advertise Contact Us
© 2007 Medical Informatics News, All Rights Reserved Worldwide